Xopenex
Product Images NDC 17478-174

20 FDA label images from Akorn · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Xopenex (NDC 17478-174). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Akorn, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Xop07 0006 01)

Chemical Structure (Xop07 0006 01)
Chemical structure diagram of the active ingredient in Xopenex showing its molecular composition, including hydroxyl groups, an amine, and a hydrochloride component, arranged with specific stereochemistry.*
FDA Label Image

Figure 1 (Xop07 0006 02)

Figure 1 (Xop07 0006 02)
A line graph depicting mean change in FEV1 (%) over time (0 to 8 hours) for different groups labeled Lev 1.25, Lev 0.63, Bac 2.5, and PBO. The data shows the response for these groups measured at various time points post-treatment, with a reference line indicating 15% change.*
FDA Label Image

Figure 2 (Xop07 0006 03)

Figure 2 (Xop07 0006 03)
A line graph showing mean changes in FEV1 (%) over 8 hours for various dosages of Xopenex compared to placebo. The x-axis represents time in hours, and the y-axis represents the percentage change in FEV1, with separate lines for dose levels 1.25, 0.63, 2.5, and placebo groups.*
FDA Label Image

Figure 3 (Xop07 0006 04)

Figure 3 (Xop07 0006 04)
A line graph showing mean change in FEV1 (%) over 4 hours, comparing different dosages of Xopenex (Levalbuterol) and placebo. The y-axis represents mean change in FEV1 (%), and the x-axis shows time in hours. Multiple lines indicate results for Levalbuterol doses (0.63, 0.31 mcg), racemic mixtures (2.5, 1.25 mcg), and placebo, demonstrating their effects on lung function over time.*
FDA Label Image

Figure 4 (Xop07 0006 05)

Figure 4 (Xop07 0006 05)
A line graph depicting mean change in FEV1 (%) over time (hours) for different treatments including Lev 0.63, Lev 0.31, Rac 2.5, Rac 1.25, and placebo (Pbo). Percentage change is shown on the vertical axis, time on the horizontal axis, with curves representing each treatment group.*
FDA Label Image

Figure A (Xop07 0006 06)

Figure A (Xop07 0006 06)
An illustration labeled 'X-top' showing a vial with instructions to twist off the tab at the top. The shaded area on the vial indicates the twist-off tab portion, and arrows point to the tab with the text 'TWIST OFF TAB' on both sides. This diagram is likely instructional for vial usage.*
FDA Label Image

Figure B (Xop07 0006 07)

Figure B (Xop07 0006 07)
An instructional illustration showing the top portion of a foil pouch or packet with a tear seam. An arrow points downward to the seam with the text 'TEAR AT SEAM,' indicating where to open the pouch. No product name or other labeling details are visible.*
FDA Label Image

Figure C (Xop07 0006 08)

Figure C (Xop07 0006 08)
Illustration showing the proper technique for using Xopenex inhaler. It depicts two hands holding the inhaler, with an arrow indicating to twist or open the top part labeled 'X-top.' This instructional diagram guides users on preparing the inhaler for use.*
FDA Label Image

Figure D (Xop07 0006 09)

Figure D (Xop07 0006 09)
An illustration showing a hand holding a vial above a device labeled with 'VIAL' and 'RESERVOIR,' indicating the vial is being placed or inserted into the reservoir of the device. No specific product details are visible in the image.*
FDA Label Image

Figure E.1 (Xop07 0006 10)

Figure E.1 (Xop07 0006 10)
An instructional diagram showing a medical device labeled with two parts: a mouthpiece on the left and a reservoir on the right side connected by a cylindrical chamber. The illustration provides a clear side view of the device.*
FDA Label Image

Figure E.2 (Xop07 0006 11)

Figure E.2 (Xop07 0006 11)
An instructional illustration showing a face mask connected to a reservoir, likely part of a respiratory or inhalation device setup. The diagram labels the 'FACE MASK' and 'RESERVOIR' components to clarify their connection.*
FDA Label Image

Figure F (Xop07 0006 12)

Figure F (Xop07 0006 12)
An illustration showing a section of a compressor labeled 'COMPRESSOR' with control knobs and a rectangular panel. Connected to the compressor is nebulizer tubing, indicated by labeled arrows, depicting how the tubing attaches to the compressor device.*
FDA Label Image

Figure G.1 (Xop07 0006 13)

Figure G.1 (Xop07 0006 13)
An instructional diagram illustrating the use of a nebulizer device. It depicts a person inhaling through the mouthpiece attached to the reservoir of the nebulizer, demonstrating the correct positioning for inhalation.*
FDA Label Image

Figure G.2 (Xop07 0006 14)

Figure G.2 (Xop07 0006 14)
An illustration showing a face mask connected to a reservoir, likely part of a medical or inhalation device setup. The face mask is depicted worn over the nose and mouth, with an arrow indicating the reservoir attachment point.*
FDA Label Image

Principal Display Panel Text For Pouch Label (Xop07 0006 15)

Principal Display Panel Text For Pouch Label (Xop07 0006 15)
Packaging label for Xopenex (levalbuterol HCl) Inhalation Solution 0.31 mg/3 mL distributed by Akorn. The label includes dosage form and strength information, storage instructions, and indicates a package size of 12 x 3 mL sterile unit-dose vials. It also displays two barcodes and mentions manufacturing by Oak Pharmaceuticals Inc.*
FDA Label Image

Principal Display Panel Text For Carton Label (Xop07 0006 16)

Principal Display Panel Text For Carton Label (Xop07 0006 16)
Packaging label for Xopenex (levalbuterol HCl) Inhalation Solution 0.31 mg/3 mL by Akorn. The box contains 24 sterile unit-dose vials, each 3 mL. The label highlights the dosage strength and includes usage as an oral inhalation solution. The label is predominantly light blue and white with green dosage indication boxes.*
FDA Label Image

Principal Display Panel Text For Pouch Label (Xop07 0006 17)

Principal Display Panel Text For Pouch Label (Xop07 0006 17)
Xopenex (levalbuterol HCl) Inhalation Solution 0.63 mg/3 mL label for 12 x 3 mL sterile unit-dose vials. The label states the active ingredient amount, storage instructions, and manufacturer details, including distribution by Akorn, Inc. and manufacturing by Oak Pharmaceuticals Inc. Features a gray background, yellow highlighted product name and strength, and multiple barcodes.*
FDA Label Image

Principal Display Panel Text For Carton Label (Xop07 0006 18)

Principal Display Panel Text For Carton Label (Xop07 0006 18)
Packaging label for Xopenex (levalbuterol HCl) Inhalation Solution 0.63 mg/3 mL by Akorn. The carton contains 24 sterile unit-dose vials, each with 3 mL of the solution for oral inhalation. The label prominently displays the brand name, active ingredient, strength, dosage form, and manufacturer details.*
FDA Label Image

Principal Display Panel Text For Pouch Label (Xop07 0006 19)

Principal Display Panel Text For Pouch Label (Xop07 0006 19)
Label for Xopenex Inhalation Solution 1.25 mg/3 mL (levalbuterol HCl) distributed by Akorn, Inc. The label indicates 12 sterile unit-dose vials per package and includes preparation and storage instructions, warnings, and other usage details. The packaging mentions that it is for prescription use only and specifies storage at 20° to 25°C.*
FDA Label Image

Principal Display Panel Text For Carton Label (Xop07 0006 20)

Principal Display Panel Text For Carton Label (Xop07 0006 20)
Packaging label for Xopenex (levalbuterol HCl) Inhalation Solution 1.25 mg/3 mL by Akorn. The carton contains 24 sterile unit-dose vials of 3 mL each. The label highlights that it is for oral inhalation use only and is Rx only. The label also includes dosage and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.